JP2012523009A5 - - Google Patents

Download PDF

Info

Publication number
JP2012523009A5
JP2012523009A5 JP2012504782A JP2012504782A JP2012523009A5 JP 2012523009 A5 JP2012523009 A5 JP 2012523009A5 JP 2012504782 A JP2012504782 A JP 2012504782A JP 2012504782 A JP2012504782 A JP 2012504782A JP 2012523009 A5 JP2012523009 A5 JP 2012523009A5
Authority
JP
Japan
Prior art keywords
markers
score
mammal
present
disease score
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012504782A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012523009A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/030104 external-priority patent/WO2010118035A2/en
Publication of JP2012523009A publication Critical patent/JP2012523009A/ja
Publication of JP2012523009A5 publication Critical patent/JP2012523009A5/ja
Pending legal-status Critical Current

Links

JP2012504782A 2009-04-06 2010-04-06 精神神経疾患の治療をモニタリングするためのバイオマーカー Pending JP2012523009A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16698609P 2009-04-06 2009-04-06
US61/166,986 2009-04-06
PCT/US2010/030104 WO2010118035A2 (en) 2009-04-06 2010-04-06 Biomarkers for monitoring treatment of neuropsychiatric diseases

Publications (2)

Publication Number Publication Date
JP2012523009A JP2012523009A (ja) 2012-09-27
JP2012523009A5 true JP2012523009A5 (https=) 2013-05-23

Family

ID=42936849

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012504782A Pending JP2012523009A (ja) 2009-04-06 2010-04-06 精神神経疾患の治療をモニタリングするためのバイオマーカー

Country Status (6)

Country Link
US (1) US20100280562A1 (https=)
EP (1) EP2417448A4 (https=)
JP (1) JP2012523009A (https=)
CN (1) CN102460153A (https=)
CA (1) CA2757659A1 (https=)
WO (1) WO2010118035A2 (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
US8868177B2 (en) * 2009-03-20 2014-10-21 ElectroCore, LLC Non-invasive treatment of neurodegenerative diseases
US8158374B1 (en) 2006-09-05 2012-04-17 Ridge Diagnostics, Inc. Quantitative diagnostic methods using multiple parameters
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
EP2337866B1 (en) * 2008-10-15 2014-07-30 Ridge Diagnostics, Inc. Human biomarker hypermapping for depressive disorders
WO2010059709A2 (en) 2008-11-18 2010-05-27 Ridge Diagnostics, Inc. Metabolic syndrome and hpa axis biomarkers for major depressive disorder
CA2757518A1 (en) * 2009-04-01 2010-10-07 Ridge Diagnostics, Inc. Biomarkers for monitoring treatment of neuropsychiatric diseases
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
CN102573986B (zh) 2009-06-09 2016-01-20 赛博恩特医疗器械公司 用于无导线刺激器的具有袋部的神经封套
US11051744B2 (en) 2009-11-17 2021-07-06 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
CN102821814B (zh) 2009-12-23 2015-07-15 赛博恩特医疗器械公司 用于治疗慢性炎症的神经刺激设备和系统
WO2011094308A2 (en) * 2010-01-26 2011-08-04 Ridge Diagnostics, Inc. Multiple biomarker panels to stratify disease severity and monitor treatment of depression
JP6074846B2 (ja) 2010-12-16 2017-02-08 国立研究開発法人産業技術総合研究所 髄液型糖タンパク質の富化及び分離方法、並びにその方法を用いた中枢神経系疾患用マーカーの探索方法及び中枢神経系疾患用マーカー
US20120238837A1 (en) * 2011-03-16 2012-09-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware System, devices, and methods for real-time monitoring of cerebrospinal fluid for markers of progressive conditions
US12172017B2 (en) 2011-05-09 2024-12-24 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US8737709B2 (en) * 2012-04-30 2014-05-27 General Electric Company Systems and methods for performing correlation analysis on clinical outcome and characteristics of biological tissue
CA3112130A1 (en) 2013-07-11 2015-01-15 University Of North Texas Health Science Center At Fort Worth Blood-based screen for detecting neurological diseases in primary care settings
AU2014354808A1 (en) * 2013-11-26 2016-06-02 University Of North Texas Health Science Center At Fort Worth Personalized medicine approach for treating cognitive loss
WO2015127476A1 (en) * 2014-02-24 2015-08-27 Setpoint Medial Corporation Vagus nerve stimulation screening test
WO2016004375A2 (en) * 2014-07-02 2016-01-07 Ridge Diagnostics, Inc. Methods and materials for treating pain and depression
US11154712B2 (en) * 2014-08-28 2021-10-26 Medtronic Ardian Luxembourg S.A.R.L. Methods for assessing efficacy of renal neuromodulation and associated systems and devices
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
WO2016126807A1 (en) 2015-02-03 2016-08-11 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
EP3405255B1 (en) 2016-01-20 2025-12-31 Setpoint Medical Corporation IMPLANTABLE MICROSTIMULATORS AND INDUCTION CHARGING SYSTEMS
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
EP3405107B1 (en) 2016-01-20 2023-04-12 Setpoint Medical Corporation Control of vagal stimulation
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
WO2018077844A1 (en) 2016-10-28 2018-05-03 Telefonica Innovacion Alpha S.L. System and a method for enabling responsive cognitive behavioral therapy
WO2018195238A1 (en) * 2017-04-20 2018-10-25 The Feinstein Institute For Medical Research Systems and methods for real-time monitoring of physiological biomarkers through nerve signals and uses thereof
WO2019036470A1 (en) * 2017-08-14 2019-02-21 Setpoint Medical Corporation TESTING TEST FOR STIMULATION OF NERVE WAVE
CN111148844A (zh) 2017-09-01 2020-05-12 韦恩生物科技股份公司 鉴定和使用糖肽作为诊断和治疗监测的生物标记物
WO2019143562A1 (en) * 2018-01-18 2019-07-25 University Of North Texas Health Science Center At Fort Worth Companion diagnostic for nsaids and donepezil for treating specific subpopulations of patients suffering from alzheimer's disease
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
AU2020272128B9 (en) 2019-04-12 2025-11-20 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
JP2023512447A (ja) 2020-01-13 2023-03-27 ザ ファインスタイン インスティチューツ フォー メディカル リサーチ 脾臓への高密度集束超音波刺激による出血及び出血性疾患の治療
CN111524596A (zh) * 2020-04-07 2020-08-11 上海市精神卫生中心（上海市心理咨询培训中心） 一种判断青少年双相障碍发病风险的方法
WO2021236977A1 (en) 2020-05-21 2021-11-25 The Feinstein Institutes For Medical Research Systems and methods for vagus nerve stimulation
WO2022245878A1 (en) 2021-05-17 2022-11-24 Setpoint Medical Corporation Neurostimulation parameter authentication and expiration system for neurostimulation
US20250229086A1 (en) 2022-01-20 2025-07-17 Setpoint Medical Corporation Treatment of inflammatory disorders

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359681A (en) * 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
US5882203A (en) * 1995-05-31 1999-03-16 Correa; Elsa I. Method of detecting depression
US5658802A (en) * 1995-09-07 1997-08-19 Microfab Technologies, Inc. Method and apparatus for making miniaturized diagnostic arrays
US5804453A (en) * 1996-02-09 1998-09-08 Duan-Jun Chen Fiber optic direct-sensing bioprobe using a phase-tracking approach
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
US20030032200A1 (en) * 2000-02-24 2003-02-13 Herath Herath Mudiyanselage Athula Chandrasiri Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (BAD) and unipolar depression
US20040110938A1 (en) * 2000-02-24 2004-06-10 Parekh Rajesh Bhikhu Proteins, genes and their use for diagnosis and treatment of schizophrenia
KR100776980B1 (ko) * 2000-03-09 2007-11-21 클리니컬 어낼리시스 코포레이션 의료진단시스템
US7118710B2 (en) * 2000-10-30 2006-10-10 Sru Biosystems, Inc. Label-free high-throughput optical technique for detecting biomolecular interactions
US6905816B2 (en) * 2000-11-27 2005-06-14 Intelligent Medical Devices, Inc. Clinically intelligent diagnostic devices and methods
EP1322957B1 (en) * 2001-05-04 2009-08-12 Biosite Incorporated Diagnostic markers of acute coronary syndromes and methods of use thereof
US6710877B2 (en) * 2001-07-23 2004-03-23 Corning Incorporated Apparatus and methods for determining biomolecular interactions
US20050095646A1 (en) * 2001-11-19 2005-05-05 Sherman Michael I. Method of using a non-antibody protein to detect and measure an analyte
US7136518B2 (en) * 2003-04-18 2006-11-14 Medispectra, Inc. Methods and apparatus for displaying diagnostic data
US20040152107A1 (en) * 2002-09-18 2004-08-05 C. Anthony Altar Gene signature of electroshock therapy and methods of use
KR20040032451A (ko) * 2002-10-09 2004-04-17 삼성전자주식회사 생체신호 기반의 건강 관리 기능을 갖는 모바일 기기 및이를 이용한 건강 관리 방법
US7490085B2 (en) * 2002-12-18 2009-02-10 Ge Medical Systems Global Technology Company, Llc Computer-assisted data processing system and method incorporating automated learning
US7418290B2 (en) * 2003-05-06 2008-08-26 Aspect Medical Systems, Inc. System and method of assessment of the efficacy of treatment of neurological disorders using the electroencephalogram
US7706871B2 (en) * 2003-05-06 2010-04-27 Nellcor Puritan Bennett Llc System and method of prediction of response to neurological treatment using the electroencephalogram
US20040228765A1 (en) * 2003-05-14 2004-11-18 Witty Thomas R. Point of care diagnostic platform
US20040228766A1 (en) * 2003-05-14 2004-11-18 Witty Thomas R. Point of care diagnostic platform
US20050084880A1 (en) * 2003-07-11 2005-04-21 Ronald Duman Systems and methods for diagnosing & treating psychological and behavioral conditions
US20070092888A1 (en) * 2003-09-23 2007-04-26 Cornelius Diamond Diagnostic markers of hypertension and methods of use thereof
US20050069936A1 (en) * 2003-09-26 2005-03-31 Cornelius Diamond Diagnostic markers of depression treatment and methods of use thereof
US7394547B2 (en) * 2003-11-06 2008-07-01 Fortebio, Inc. Fiber-optic assay apparatus based on phase-shift interferometry
JP2005312435A (ja) * 2004-03-29 2005-11-10 Kazuhito Rokutan うつ病の評価方法
US20050254065A1 (en) * 2004-05-12 2005-11-17 Stokowski Stanley E Method and apparatus for detecting surface characteristics on a mask blank
AU2005257705A1 (en) * 2004-06-24 2006-01-05 Ge Healthcare Bio-Sciences Ab Method for detecting molecular surface interactions
US20060063199A1 (en) * 2004-09-21 2006-03-23 Elgebaly Salwa A Diagnostic marker
US7445887B2 (en) * 2005-01-07 2008-11-04 Fortebio, Inc. Enzyme activity measurements using bio-layer interferometry
JP2007024822A (ja) * 2005-07-21 2007-02-01 Aska Pharmaceutical Co Ltd 男性の更年期又はうつ病の鑑別方法
EP1949123A2 (en) * 2005-10-18 2008-07-30 Cambridge Enterprise Limited Methods and biomarkers for diagnosing and monitoring psychotic disorders
US20070161042A1 (en) * 2006-01-11 2007-07-12 Fortebio, Inc. Methods for characterizing molecular interactions
WO2007094472A1 (ja) * 2006-02-17 2007-08-23 Atsuo Sekiyama 生体負荷の指標剤および生体負荷の測定方法
US20080015465A1 (en) * 2006-06-15 2008-01-17 Scuderi Gaetano J Methods for diagnosing and treating pain in the spinal cord
US7651836B2 (en) * 2006-08-04 2010-01-26 Hospital Santiago Apóstol Methods for diagnosis and prognostic of psychiatric diseases
US8158374B1 (en) * 2006-09-05 2012-04-17 Ridge Diagnostics, Inc. Quantitative diagnostic methods using multiple parameters
US20080199866A1 (en) * 2006-10-10 2008-08-21 The Board Of Trustees Of The Leland Stanford Junior University Snp detection and other methods for characterizing and treating bipolar disorder and other ailments
WO2008099972A1 (ja) * 2007-02-16 2008-08-21 Shimadzu Corporation 上皮性卵巣癌の組織型識別マーカー、及びそれを用いた組織型に基づく上皮性卵巣癌の罹患の識別法
US20080281531A1 (en) * 2007-03-15 2008-11-13 Kazuhito Rokutan Method for Diagnosing Depression
CN102037355A (zh) * 2008-03-04 2011-04-27 里奇诊断学股份有限公司 基于多重生物标记物板块诊断和监测抑郁症
EP2272044A4 (en) * 2008-03-12 2011-07-06 Ridge Diagnostics Inc INFLAMMATORY BIOMARKING FOR MONITORING DEPRESSION DISEASES
EP2337866B1 (en) * 2008-10-15 2014-07-30 Ridge Diagnostics, Inc. Human biomarker hypermapping for depressive disorders
WO2010059709A2 (en) * 2008-11-18 2010-05-27 Ridge Diagnostics, Inc. Metabolic syndrome and hpa axis biomarkers for major depressive disorder
CA2757518A1 (en) * 2009-04-01 2010-10-07 Ridge Diagnostics, Inc. Biomarkers for monitoring treatment of neuropsychiatric diseases
WO2011094308A2 (en) * 2010-01-26 2011-08-04 Ridge Diagnostics, Inc. Multiple biomarker panels to stratify disease severity and monitor treatment of depression
JP2014500503A (ja) * 2010-12-06 2014-01-09 リッジ ダイアグノスティックス，インコーポレイテッド 精神神経疾患の処置をモニタリングするためのバイオマーカー

Similar Documents

Publication Publication Date Title
JP2012523009A5 (https=)
JP2012522995A5 (https=)
Klyucherev et al. Advances in the development of new biomarkers for Alzheimer’s disease
Iwata et al. White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis
Maestri et al. Non-rapid eye movement sleep instability in mild cognitive impairment: a pilot study
JP2022501016A5 (https=)
Hiskens et al. Blood biomarkers for assessment of mild traumatic brain injury and chronic traumatic encephalopathy
Yang et al. Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer’s disease
EP3134552B1 (en) Methods, processes, devices and kits for the measurement of post traumatic stress disorder microrna markers
Sylvestre et al. Untargeted metabolomic analysis of plasma from relapsing-remitting multiple sclerosis patients reveals changes in metabolites associated with structural changes in brain
Mayeli et al. Shared and distinct abnormalities in sleep-wake patterns and their relationship with the negative symptoms of schizophrenia spectrum disorder patients
WO2020125530A1 (zh) D-丝氨酸作为标志物在制备抑郁症诊断试剂盒中的应用及抑郁症诊断试剂盒
JP2009515183A5 (https=)
WO2024074133A1 (en) Protein marker for assessing and treating neurodegenerative diseases
Myhr et al. The N orwegian M ultiple S clerosis R egistry and B iobank
Wei et al. Differential neuropsychiatric associations of plasma biomarkers in older adults with major depression and subjective cognitive decline
Dadsena et al. Evidence of clinical and brain recovery in post-COVID-19 condition: a three-year follow-up study
Chan Early diagnosis, monitoring, and treatment of optic neuritis
KR102184840B1 (ko) 외상 후 스트레스 장애 진단 또는 예측용 바이오마커 및 그의 용도
Fuller et al. Current and developing methods for diagnosing Alzheimer's disease
McFarlane et al. DSP-01 conversion from PLS to ALS: a Dutch cohort study.
Penner Effects of Interval Exercise on Commonly Studied Fluid Biomarkers for Sport-related Concussion in Serum and Plasma
van der Ende Fluid Biomarkers in Genetic Frontotemporal Dementia
RU2506901C1 (ru) Способ прогнозирования развития сосудистых нарушений у больных гриппом
JP2023030598A (ja) 唾液中のうつ病バイオマーカー